Algoma Capital and InvestBev Establish Lending Platform to Provide Financing to the Craft Spirits Industry
CHICAGO–(BUSINESS WIRE)–With over 40 years of industry expertise, Brian Rosen has established a specialty lending…
CHICAGO–(BUSINESS WIRE)–With over 40 years of industry expertise, Brian Rosen has established a specialty lending…
Li-Cycle assessing opportunity to develop a dedicated Spoke recycling plant in Vietnam near VinES’ lithium-ion…
To address the global demand for high-quality face recognition as a part of identity verification,…
SAN FRANCISCO–(BUSINESS WIRE)–Mintegral, a prominent global programmatic advertising platform for app developers, recently revealed its…
KARIYA, JAPAN, Apr 12, 2023 – (JCN Newswire) – DENSO, a leading mobility supplier, has…
SEOUL, South Korea/TOKYO, Japan, Apr 12, 2023 – (JCN Newswire) – POSCO Holdings Inc. (POSCO)…
MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–intoPIX and Lawo proudly announce that, following the popularity of Lawo’s vm_jpegXS app…
SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and…
JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2023 (GLOBE NEWSWIRE) —…
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400…
Vancouver, British Columbia–(Newsfile Corp. – April 11, 2023) – Destiny Media Technologies Inc. (TSXV: DSY)…
Victoria, British Columbia–(Newsfile Corp. – April 11, 2023) – WeCommerce Holdings Ltd. (TSXV: WE) (“WeCommerce”…
Hong Kong-based conglomerate strengthens service delivery through the Boomi platform, taking digital transformation to the…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company…
UCART22 is currently the most advanced allogeneic CAR T-cell product in development for relapsed or…
MONMOUTH JUNCTION, N.J., April 11, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…